Germline mutations of the tumor suppressor gene TP53 account for more than half of the families with classic Li-Fraumeni syndrome (LFS)[1], which is an inherited condition characterized by the development of sarcomas and other early-onset tumors, including breast cancer[2,3]. Here, TP53 is linked to Li-Fraumeni syndrome.